Roche and Ionis Report Phase 3 Proteinuria Win for Sefaxersen in IgA Nephropathy

Roche-Ionis sefaxersen beat placebo on proteinuria at week 37 in IgAN Phase 3. Monthly shot enters crowded market vs Novartis Fabhalta.